Sinopharm Group Co. Ltd. (SHTDY)
SHTDY Stock Price Chart
Explore Sinopharm Group Co. Ltd. interactive price chart. Choose custom timeframes to analyze SHTDY price movements and trends.
SHTDY Company Profile
Discover essential business fundamentals and corporate details for Sinopharm Group Co. Ltd. (SHTDY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
25 Aug 2016
Employees
108.22K
CEO
Wanyong Lian
Description
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
SHTDY Financial Timeline
Browse a chronological timeline of Sinopharm Group Co. Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Apr 2026
Upcoming earnings on 19 Mar 2026
Upcoming earnings on 23 Oct 2025
Earnings released on 21 Aug 2025
Dividend declared on 19 May 2025
A dividend of $0.47 per share was announced, adjusted to $0.47. The dividend was paid on 27 Aug 2025.
Earnings released on 25 Apr 2025
Earnings released on 21 Mar 2025
Earnings released on 25 Oct 2024
Earnings released on 23 Aug 2024
EPS came in at $0.10 , while revenue for the quarter reached $20.29B .
Dividend declared on 18 Jun 2024
A dividend of $0.60 per share was announced, adjusted to $0.60. The dividend was paid on 28 Aug 2024.
Earnings released on 26 Apr 2024
EPS came in at $0.06 , while revenue for the quarter reached $20.36B .
Earnings released on 22 Mar 2024
EPS came in at $0.09 , while revenue for the quarter reached $19.84B .
Earnings released on 31 Dec 2023
EPS came in at $0.13 , while revenue for the quarter reached $21.27B .
Earnings released on 30 Jun 2023
EPS came in at $0.11 , while revenue for the quarter reached $21.45B .
Dividend declared on 15 Jun 2023
A dividend of $0.60 per share was announced, adjusted to $0.60. The dividend was paid on 29 Aug 2023.
Earnings released on 31 Mar 2023
EPS came in at $0.07 , while revenue for the quarter reached $21.16B .
Earnings released on 31 Dec 2022
EPS came in at $0.12 , while revenue for the quarter reached $21.29B .
Earnings released on 30 Sept 2022
EPS came in at $0.10 , while revenue for the quarter reached $20.28B .
Earnings released on 30 Jun 2022
EPS came in at $0.11 , while revenue for the quarter reached $19.97B .
Dividend declared on 24 Jun 2022
A dividend of $0.59 per share was announced, adjusted to $0.59. The dividend was paid on 7 Sept 2022.
Earnings released on 31 Mar 2022
EPS came in at $0.07 , while revenue for the quarter reached $20.08B .
Earnings released on 31 Dec 2021
EPS came in at $0.10 , while revenue for the quarter reached $21.95B .
Earnings released on 30 Sept 2021
EPS came in at $0.11 , while revenue for the quarter reached $20.48B .
Earnings released on 30 Jun 2021
EPS came in at $0.12 , while revenue for the quarter reached $19.92B .
Dividend declared on 14 Jun 2021
A dividend of $0.53 per share was announced, adjusted to $0.53. The dividend was paid on 25 Aug 2021.
Earnings released on 31 Mar 2021
EPS came in at $0.06 , while revenue for the quarter reached $18.32B .
Earnings released on 31 Dec 2020
EPS came in at $0.10 , while revenue for the quarter reached $19.73B .
Earnings released on 30 Sept 2020
EPS came in at $0.11 , while revenue for the quarter reached $18.22B .
SHTDY Stock Performance
Access detailed SHTDY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.